Treatment results in males with breast cancer

Robison, Roger F.; Montague, Eleanor D.

doi:10.1016/0360-3016(80)90523-4

Cited by 6 publications

(10 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A higher age at diagnosis does not entail a worse prognosis, according to our study and several others in which survival figures corrected for age have been compared (Morgan, 1969;Mausner, 1969;Peltokallio & Kalima, 1969;The Cancer Registry of Norway, 1975;Robison & Montague, 1982). The finding contrasts with the regular trend toward a more favourable course in younger patients, which was recently established for female breast cancer in Sweden (Adami et al, 1985).…”

Section: Discussionsupporting

confidence: 45%

“…We therefore consider the validity of the study as acceptable, and accordingly regard the results as representative for the Swedish population. Although the results are based, as far as we know, on the largest material published hitherto, the number of patients available for analysis after more than 10 years was so small that the possible influence of a sampling error ( Mausner 1969;Crichlow et al, 1972b;Langlands 8~~~~~~~~~~et al, 1976;Ribeiro, 1977;Morgan, 1979;Robison & Montague, 1982) showed that the Swedish 0~~~~~~~~patients had approximately the same clinical picture F-~~~~~~~~~a t presentation and included the same proportion of cases in stage I. However, there were somewhat more patients in stage II, whereas in other series there have been more stage III and IV patients.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Long-term survival in 406 males with breast cancer

Adami¹,

Holmberg²,

Malker³

et al. 1985

Br J Cancer

View full text Add to dashboard Cite

Summary Survival was analyzed during a follow-up period of up to 20 years in 406 (97%) of all 420 males in whom breast cancer was diagnosed in Sweden in 1960Sweden in -1978. After correction for the expected mortality in the general population, cumulated survival rates (with 95% confidence limits) of 66 (58.7-72.5)% and 52 (42.0-62.1)% at 5 and 10 years respectively were found. These figures and the general pattern of relative survival rates were in close accordance with those noted in a concomitant series of female breast cancer. There was a trend toward slightly improved survival rates during the period of study and the median survival times were 3.9, 4.8 and 7.2 years for patients diagnosed in 1960-64, 1965-69 and 1970-74 respectively. Age at diagnosis was seemingly unrelated to the long-term relative survival. We conclude that, except for a slightly higher mean age at diagnosis in males, there is a striking similarity in the natural history of breast cancer between men and women after initial treatment, with an excess death rate which still persists at long-term observation.

show abstract

Section: Discussionsupporting

confidence: 45%

Section: Discussionmentioning

confidence: 99%

Long-term survival in 406 males with breast cancer

Adami¹,

Holmberg²,

Malker³

et al. 1985

Br J Cancer

View full text Add to dashboard Cite

show abstract

“…Like in female breast cancer the most important prognostic factors are tumor size and lymph node status both of which are strongly correlated: N+ in 25% of patients with T1 tumor versus 60% in patients with T4 tumors [7]. Relative 5-year survival rate of node-negative patients amounted to favorable 80-85% as opposed to 30% of nodepositive patients [6,[9][10][11]. When allowing for the major prognostic factors, the outcomes of female and male breast carcinoma seem to be comparable [5,6,12].…”

Section: Discussionmentioning

confidence: 99%

Radiotherapy of Male Breast Cancer

Höller¹,

Höcht²,

Runkel³

et al. 1999

Oncol Res Treat

View full text Add to dashboard Cite

Background: Male breast cancer (MBC) is a rare disease. This study reports the results of a treatment including radiotherapy of a single institution. Material and Methods: The hospital charts of 23 patients with nonmetastatic MBC treated from 1971 to 1991 were reviewed. The tumor was located centrally or medially in 10 patients. Tumor classification: Tis C3 n =1, pT1 n = 2, pT2 n = 8, T2 C3 n =1, pT3 n = 4, pT4 n = 6, unknown n =1, cN0 n = 8, cN+ n =1, pN0 n = 5, pN+ n = 9. Biopsy only was performed in 2 patients, tumorectomy in 2 patients and radical or modified radical mastectomy in 19 patients. Radiotherapy was given to the chest wall (median total dose 46 Gy) in all patients but two (who had only irradiation of the nodes) and to the axillary/supraclavicular nodes (median total dose 48 Gy) in all patients but two (who had only chest wall irradiation). In 5 patients radiation of the mammaria interna nodes was added to the supraclavicular field (median total dose 48 Gy). 5 patients with known receptor status were treated with adjuvant hormone therapy. Median follow-up was 62 (6–182) months. Results: 19 patients died, 15 with tumor. The median overall survival time was 63 months, the disease-specific 5-year and 10-year survival rate was 69% and 35%, respectively. There were 3 chest wall relapses in one of two nonirradiated patients and in one of two only irradiated patients, respectively. Distant metastases occurred in 12 patients. Conclusion: This study supports adjuvant radiotherapy for treatment of advanced male breast cancer.

show abstract

“…Zur Optimierung der lokalen Tumorkontrolle sollte zumindest bei größeren Primärtumoren (> 2-3 cm), insbesondere wenn Haut-und/oder Burstwandinfiltration vorliegt oder mehrere tumorbefallene Lymphknoten gefunden werden, eine Nachbestrahlung vorgenommen werden. Wahl der Bestrahlungsfelder und Dosis sind am Vorgehen beim Mammakarzinom der Frau orientiert [40][41][42]. Wegen der meist zentralen Lage der Tumoren ist ein homolaterales Parasternalfeld einzubeziehen.…”

Section: Strahlentherapieunclassified

Therapiestrategien beim Mammakarzinom des Mannes

Stierer¹

1998

Oncol Res Treat

View full text Add to dashboard Cite

Treatment results in males with breast cancer

Cited by 6 publications

References 0 publications

Long-term survival in 406 males with breast cancer

Long-term survival in 406 males with breast cancer

Radiotherapy of Male Breast Cancer

Therapiestrategien beim Mammakarzinom des Mannes

Contact Info

Product

Resources

About